Using patient-derived xenograft mice models in which the heterogeneity of the primary human tumor was preserved, we found that simultaneous blockade of YAP1 and STAT3 by verteporfin suppressed CSC activity and tumor growth when combined with chemotherapy. Here, YAP1 is linked to neoplasm.